Management of an expansile orbital mass: Plexiform neurofibroma decompression by orbitozygomatic approach.

about

Management of an expansile orbital mass: Plexiform neurofibroma decompression by orbitozygomatic approach.

Item

http://www.wikidata.org/entity/Q48184623

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Management of an expansile orb ...... n by orbitozygomatic approach.

@en

Management of an expansile orb ...... n by orbitozygomatic approach.

@nl

type

Item

label

Management of an expansile orb ...... n by orbitozygomatic approach.

@en

Management of an expansile orb ...... n by orbitozygomatic approach.

@nl

prefLabel

Management of an expansile orb ...... n by orbitozygomatic approach.

@en

Management of an expansile orb ...... n by orbitozygomatic approach.

@nl

P1476

Management of an expansile orb ...... n by orbitozygomatic approach.

@en

P2093

Christopher H Rassekh

http://www.w3.org/2001/XMLSchema#string

Kevin J Kovatch

http://www.w3.org/2001/XMLSchema#string

Laurie A Loevner

http://www.w3.org/2001/XMLSchema#string

M Sean Grady

http://www.w3.org/2001/XMLSchema#string

Michael T Purkey

http://www.w3.org/2001/XMLSchema#string

Roberta E Gausas

http://www.w3.org/2001/XMLSchema#string

P2860

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.

Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas.

Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

Plexiform neurofibroma of the eye region occurring in patients without neurofibromatosis type 1.

Intraorbital plexiform neurofibroma in an NF-1-negative patient.

Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service

P304

2457-2460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LARY.25232

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Maria Martinez-Lage

Bert W. O'Malley

P577

2015-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25960281

http://www.w3.org/2001/XMLSchema#string